Renaissance Technologies - NOVELION THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 68 filers reported holding NOVELION THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.13 and the average weighting 0.4%.

Links
Filings
External links
Quarter-by-quarter ownership
Renaissance Technologies ownership history of NOVELION THERAPEUTICS INC
ValueSharesWeighting
Q2 2017$1,355,000
-33.6%
146,839
-22.8%
0.00%
-33.3%
Q1 2017$2,042,000
-27.1%
190,110
-42.9%
0.00%
-25.0%
Q4 2016$2,803,000–332,870–0.00%–
 Download
Other shareholders

There were no reported owners of NOVELION THERAPEUTICS INC in Q4 2016.

NameSharesValueWeighting ↓
View complete list of NOVELION THERAPEUTICS INC shareholders